Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1968 Jan 20;1(5585):135–144. doi: 10.1136/bmj.1.5585.135

Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison

B N C Prichard, A W Johnston, I D Hill, M L Rosenheim
PMCID: PMC1984601  PMID: 20791420

Full text

PDF
135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOURA A. L., GREEN A. F. Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines. Br J Pharmacol Chemother. 1962 Aug;19:13–41. doi: 10.1111/j.1476-5381.1962.tb01424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CANNON P. J., WHITLOCK R. T., MORRIS R. C., ANGERS M., LARAGH J. H. Effect of alpha-methyl DOPA in severe and malignant hypertension. JAMA. 1962 Mar 3;179:673–681. doi: 10.1001/jama.1962.03050090001001. [DOI] [PubMed] [Google Scholar]
  3. CONWAY J., LAUWERS P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation. 1960 Jan;21:21–27. doi: 10.1161/01.cir.21.1.21. [DOI] [PubMed] [Google Scholar]
  4. CRANSTON W. I., JUEL-JENSEN B. E., SEMMENCE A. M., JONES R. P., FORBES J. A., MUTCH L. M. EFFECTS OF ORAL DIURETICS ON RAISED ARTERIAL PRESSURE. Lancet. 1963 Nov 9;2(7315):966–970. doi: 10.1016/s0140-6736(63)90671-8. [DOI] [PubMed] [Google Scholar]
  5. DAY M. D., RAND M. J. A hypothesis for the mode of action of alpha-methyldopa in relieving hypertension. J Pharm Pharmacol. 1963 Apr;15:221–224. doi: 10.1111/j.2042-7158.1963.tb12778.x. [DOI] [PubMed] [Google Scholar]
  6. DOLLERY C. T., EMSLIE-SMITH D., MILNE M. D. Clinical and pharmacological studies with guanethidine in the treatment of hypertension. Lancet. 1960 Aug 20;2(7147):381–387. doi: 10.1016/s0140-6736(60)92836-1. [DOI] [PubMed] [Google Scholar]
  7. DOLLERY C. T., HARINGTON M. Methyldopa in hypertension. Clinical and pharmacological studies. Lancet. 1962 Apr 14;1(7233):759–763. doi: 10.1016/s0140-6736(62)91781-6. [DOI] [PubMed] [Google Scholar]
  8. FREIS E. D., WANKO A., WILSON I. M., PARRISH A. E. Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents. J Am Med Assoc. 1958 Jan 11;166(2):137–140. doi: 10.1001/jama.1958.02990020025004. [DOI] [PubMed] [Google Scholar]
  9. GIFFORD R. W., Jr BETHANIDINE SULFATE--A NEW ANTIHYPERTENSIVE AGENT. JAMA. 1965 Sep 13;193:901–905. doi: 10.1001/jama.1965.03090110039011. [DOI] [PubMed] [Google Scholar]
  10. GOLDBERG L. I., ZIMMERMAN A. M. Guanethidine and methyldopa as therapeutic agents in hypertension. A comparative review. Postgrad Med. 1963 Jun;33:548–554. doi: 10.1080/00325481.1963.11692905. [DOI] [PubMed] [Google Scholar]
  11. HAMILTON M., KOPELMAN H. Treatment of severe hypertension with methyldopa. Br Med J. 1963 Jan 19;1(5324):151–155. doi: 10.1136/bmj.1.5324.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnson P., Kitchin A. H., Lowther C. P., Turner R. W. Treatment of hypertension with methyldopa. Br Med J. 1966 Jan 15;1(5480):133–137. doi: 10.1136/bmj.1.5480.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LEISHMAN A. W., MATTHEWS H. L., SMITH A. J. Guanethidine; hypotensive drug with prolonged action. Lancet. 1959 Dec 12;2(7111):1044–1048. doi: 10.1016/s0140-6736(59)91526-0. [DOI] [PubMed] [Google Scholar]
  14. LOWTHER C. P., TURNER R. W. GUANETHIDINE IN THE TREATMENT OF HYPERTENSION. Br Med J. 1963 Sep 28;2(5360):776–781. doi: 10.1136/bmj.2.5360.776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Oates J. A., Seligmann A. W., Clark M. A., Rousseau P., Lee R. E. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med. 1965 Sep 30;273(14):729–734. doi: 10.1056/NEJM196509302731402. [DOI] [PubMed] [Google Scholar]
  16. PAGE I. H., DUSTAN H. P. A new, potent antihypertensive drug: preliminary study of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (guanethidine). J Am Med Assoc. 1959 Jul 11;170(11):1265–1271. doi: 10.1001/jama.1959.03010110013003. [DOI] [PubMed] [Google Scholar]
  17. ROSE G. A., HOLLAND W. W., CROWLEY E. A. A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS. Lancet. 1964 Feb 8;1(7328):296–300. doi: 10.1016/s0140-6736(64)92408-0. [DOI] [PubMed] [Google Scholar]
  18. SMIRK H. Hypotensive action methyldopa. Br Med J. 1963 Jan 19;1(5324):146–151. doi: 10.1136/bmj.1.5324.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SMIRK H. The hypotensive action of B.W. 467C60. Lancet. 1963 Apr 6;1(7284):743–746. doi: 10.1016/s0140-6736(63)91565-4. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES